H.R. 5659: ESRD Choice Act of 2016.
21st Century Cures Act as it relates to potential offsets.
Duration: January 1, 2011
to
December 31, 2016
General Issues: Medicare/Medicaid , Health Issues , Defense , Veterans , Government Issues , Taxation/Internal Revenue Code , Budget/Appropriations
Spending: about $1,200,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2011: House of Representatives, Defense - Dept of (DOD), U.S. Senate, House of Representatives,, U.S. Senate,
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Darren Willcox
Asst for Policy, Speaker Dennis Hastert
Admin Asst; Leg Dir; Leg Asst, Cong. Porter Goss
House Rules Comm Assoc, Subcomm Staff Dir.
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
4th Quarter, 2016
W Strategies, LLC terminated an engagement in which they represented UnitedHealth Group, Inc. on Dec. 31, 2016.
Original Filing: 300843330.xml
Lobbying Issues
H.R. 5659: ESRD Choice Act of 2016.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
21st Century Cures Act as it relates to potential offsets.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2016
In Q3, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on Oct. 20, 2016.
Original Filing: 300835196.xml
Lobbying Issues
H.R. 5659: ESRD Choice Act of 2016.
Agencies Lobbied
U.S. House of Representatives Defense - Dept of (DOD)
Lobbying Issues
FY 2017 National Defense Authorization Act.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2016
In Q2, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on July 20, 2016.
Original Filing: 300821728.xml
Lobbying Issues
FY 2017 CMS Advance Notice for Medicare Advantage, as it relates to proposed cuts to MA Employer Group Waiver Plans.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R.3717: Helping Families in Mental Health Crisis Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
S.2921: Veterans First Act.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2016
In Q1, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on April 20, 2016.
Original Filing: 300803094.xml
Lobbying Issues
FY 2017 CMS Advance Notice for Medicare Advantage, as it relates to proposed cuts to MA Employer Group Waiver Plans.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2015
In Q4, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on Jan. 19, 2016.
Original Filing: 300776337.xml
Lobbying Issues
FY 2015 CMS Hospital Inpatient PPS rule as it relates to two midnights policy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to expand competition in the Federal Employee Health Benefits Program (FEHBP).
Lobbying Issues
H.R. 6: 21st Century Cures Act and James Zadroga 9/11 Health and Compensation Reauthorization as they relate to provisions affecting reimbursement of Part D prescription drug plans.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Education about the Tricare and VA health programs.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
P.L. 114-113 "Consolidated Appropriations Act" with respect to the Protecting Americans from Tax Hikes Act and language related to delay in excise tax on high value health plans.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
P.L. 114-74: Bipartisan Budget Act of 2015.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2015
In Q3, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on Oct. 20, 2015.
Original Filing: 300763699.xml
Lobbying Issues
FY 2015 CMS Hospital Inpatient PPS rule as it relates to two midnights policy.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Legislation to expand competition in the Federal Employee Health Benefits Program (FEHBP).
Lobbying Issues
H.R. 6: 21st Century Cures Act as it relates to provisions affecting reimbursement of Part D prescription drug plans.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Education about the Tricare and VA health programs.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2015
In Q2, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on July 20, 2015.
Original Filing: 300743530.xml
Lobbying Issues
Education on the value of Medicare Advantage and opposition to cuts in reimbursement for Medicare Advantage plans, specifically with respect to the CMS 2016 Medicare Advantage call letter.
FY 2015 CMS Hospital Inpatient PPS rule as it relates to two midnights policy.
H.R. 2506: Seniors Health Plan Protection Act of 2015.
H.R. 2570: Strengthening Medicare Advantage Through Innovation and Transparency Act.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Legislation to expand competition in the Federal Employee Health Benefits Program (FEHBP).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 6: 21st Century Cures Act as it relates to provisions affecting reimbursement of Part D prescription drug plans.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2015
In Q1, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on April 17, 2015.
Original Filing: 300718843.xml
Lobbying Issues
Education on the value of Medicare Advantage and opposition to cuts in reimbursement for Medicare Advantage plans, specifically with respect to the CMS 2016 Medicare Advantage call letter.
FY 2015 CMS Hospital Inpatient PPS rule as it relates to two midnights policy.
H.R. 2: Medicare Access and CHIP Reauthorization Act of 2015.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Legislation to expand competition in the Federal Employee Health Benefits Program (FEHBP).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2014
In Q4, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on Jan. 20, 2015.
Original Filing: 300704114.xml
Lobbying Issues
Education on the value Medicare Advantage and opposition to cuts in reimbursement for Medicare Advantage plans.
FY 2015 CMS Hospital Inpatient PPS rule as it relates to "two midnights" policy.
Hospital Improvements for Payment Act of 2014.
H.R. 647: ABLE Act of 2014.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 763: To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Legislation to expand competition in the Federal Employee Health Benefits Program (FEHBP).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 3979: National Defense Authorization Act for Fiscal Year 2015.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3547: FY 2015 Consolidated Appropriations Act.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2014
In Q3, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on Oct. 17, 2014.
Original Filing: 300684756.xml
Lobbying Issues
Education on the value Medicare Advantage and opposition to cuts in reimbursement for Medicare Advantage plans.
H.R. 2753: Securing Care for Seniors Act.
FY 2015 CMS Hospital Inpatient PPS rule as it relates to "two midnights" policy.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 763: To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Legislation to expand competition in the Federal Employee Health Benefits Program (FEHBP).
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 4810: Veteran Access to Care Act of 2014.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.J. Res. 124, FY 2015 Continuing Appropriations Resolution.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2014
In Q2, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on July 14, 2014.
Original Filing: 300668276.xml
Lobbying Issues
Education on the value of Medicare Advantage and opposition to cuts in reimbursement for Medicare Advantage plans.
Advance Notice of Methodological Changes for Calendar Year (CY) 2015 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2015 Call Letter.
CMS proposed rule affecting the Medicare Advantage and Medicare Prescription Drug Benefit (Part D) Programs, specifically as it relates to changes in pharmacy networks.
H.R. 2753: Securing Care for Seniors Act.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 763: To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Legislation to expand competition in the Federal Employee Health Benefits Program (FEHBP).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 4810: Veteran Access to Care Act of 2014.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2014
In Q1, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on April 14, 2014.
Original Filing: 300635686.xml
Lobbying Issues
Education on the value of Medicare Advantage and opposition to cuts in reimbursement for Medicare Advantage plans.
H.R. 4160: Keep the Promise to Seniors Act of 2014.
Advance Notice of Methodological Changes for Calendar Year (CY) 2015 for Medicare Advantage (MA) Capitation Rates, Part C and Part D Payment Policies and 2015 Call Letter.CMS proposed rule affecting the Medicare Advantage and Medicare Prescription Drug Benefit (Part D) Programs, specifically as it relates to changes in pharmacy networks.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 763: To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Legislation to expand competition in the Federal Employee Health Benefits Program (FEHBP).
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2013
In Q4, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on Jan. 14, 2014.
Original Filing: 300621930.xml
Lobbying Issues
Educated Congressional staff about a legislative proposal to create a comprehensive care option in Medicare which adds clinical innovations to yield better patient outcomes and reduces program costs.
Education on the value of Medicare Advantage and opposition to cuts in reimbursement for Medicare Advantage plans.FY 2014 IPPS rule as it relates to "two midnights" benchmark.
H.R. 2810, S: Medicare Patient Access and Quality Improvement Act of 2013.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 763: To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Legislation to expand competition in the Federal Employee Health Benefits Program (FEHBP).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.J. Res. 59 The Bipartisan Budget Act of 2013 Public Law No: 113-067.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2013
In Q3, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on Oct. 16, 2013.
Original Filing: 300601827.xml
Lobbying Issues
Educated Congressional staff about a legislative proposal to create a comprehensive care option in Medicare which adds clinical innovations to yield better patient outcomes and reduces program costs.
Education on the value of Medicare Advantage and opposition to cuts in reimbursement for Medicare Advantage plans.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 763: To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Legislation to expand competition in the Federal Employee Health Benefits Program (FEHBP).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Educated staff about transition in the Tricare program in the West Region.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
W Strategies, LLC amended a lobbying report for representation of UnitedHealth Group, Inc. in Q22013 on July 22, 2013.
Original Filing: 300583386.xml
Lobbying Issues
Educated Congressional staff about a legislative proposal to create a comprehensive care option in Medicare which adds clinical innovations to yield better patient outcomes and reduces program costs.
Education on the value of Medicare Advantage and opposition to cuts in reimbursement for Medicare Advantage plans.Education and advocacy to assume a stable Sustainable Growth rate formula for physicians as CMS develops payment rates for Medicare Advantage plans.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 763: To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Legislation to expand competition in the Federal Employee Health Benefits Program (FEHBP).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Educated staff about transition in the Tricare program in the West Region.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2013
In Q2, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on July 18, 2013.
Original Filing: 300577272.xml
Lobbying Issues
Educated Congressional staff about a legislative proposal to create a comprehensive care option in Medicare which adds clinical innovations to yield better patient outcomes and reduces program costs.
Education on the value of Medicare Advantage and opposition to cuts in reimbursement for Medicare Advantage plans.Education and advocacy to assume a stable Sustainable Growth rate formula for physicians as CMS develops payment rates for Medicare Advantage plans.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 763: To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2013
In Q1, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on April 18, 2013.
Original Filing: 300558912.xml
Lobbying Issues
Educated Congressional staff about a legislative proposal to create a comprehensive care option in Medicare which adds clinical innovations to yield better patient outcomes and reduces program costs.
Education on the value of Medicare Advantage and opposition to cuts in reimbursement for Medicare Advantage plans.H.R. 8: American Taxpayer Relief Act of 2012 as it relates to sequestration and Medicare, including updates to the Medicare Sustainable Growth rate formula for physicians and related issues.
Education and advocacy to assume a stable Sustainable Growth rate formula for physicians as CMS develops payment rates for Medicare Advantage plans.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 763: To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2012
In Q4, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on Jan. 20, 2013.
Original Filing: 300542512.xml
Lobbying Issues
Educated Congressional staff about a legislative proposal to create a comprehensive care option in Medicare which adds clinical innovations to yield better patient outcomes and reduces program costs.
Education on the value of Medicare Advantage and opposition to cuts in reimbursement for Medicare Advantage plans.
H.R. 8: American Taxpayer Relief Act of 2012 as it relates to sequestration and Medicare, including updates to the Medicare Sustainable Growth rate formula for physicians and related issues.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 1370: To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
S. 1880: Jobs and Premium Protection Act.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2012
In Q3, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on Oct. 10, 2012.
Original Filing: 300512174.xml
Lobbying Issues
Educated Congressional staff about modernizing the Medicare program.
H.R. 3399: Medicare and Medicaid FAST Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 1370: To repeal the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
Lobbying Issues
Educated Congressional staff about award of DOD TRICARE Managed Care Support contract in the West Region.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2012
In Q2, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on July 17, 2012.
Original Filing: 300489956.xml
Lobbying Issues
Educated Congressional staff about modernizing the Medicare program, including providing greater patient and provider incentives.
H.R. 3399: Medicare and Medicaid FAST Act.
Agencies Lobbied
U.S. House of Representatives,
Lobbying Issues
Advocated for legislative changes to the Federal Employees Health Benefit Program to promote greater health plan choices for federal employees and retirees.
Lobbying Issues
Educated Congressional staff about award of DOD TRICARE Managed Care Support contract in the West Region.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2012
In Q1, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on April 4, 2012.
Original Filing: 300464056.xml
Lobbying Issues
Educated Congressional staff on legislative efforts to address diabetes prevention in the Medicare program.
Congressional hearing on physician reimbursement models under Medicare.
Educated Congressional staff about modernizing the Medicare program, including providing greater patient and provider incentives.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocated for legislative changes to the Federal Employees Health Benefit Program to promote greater health plan choices for federal employees and retirees.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Outreach to Congressional staff about award of DOD TRICARE Managed Care Support contract in the West Region.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2011
In Q4, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on Jan. 18, 2012.
Original Filing: 300445661.xml
Lobbying Issues
Monitored deficit reduction initiatives related to enactment of an increase in the U.S. federal debt ceiling.
P.L. 112-25 - The Budget Control Act of 2011 as it relates to coverage of dual eligibles.
Educated about proposals to reform the Medicaid program and general issues related to deficit reduction.
Education for Congressional staff on efforts to address prescription drug diversion and abuse in the Medicare program.Educated Congressional on legislative efforts to address diabetes prevention in the Medicare program.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Advocated for legislative changes to the Federal Employees Health Benefit Program to promote greater health plan choices for federal employees and retirees.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2011
In Q3, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on Oct. 20, 2011.
Original Filing: 300424191.xml
Lobbying Issues
Monitored deficit reduction initiatives related to enactment of an increase in the U.S. federal debt ceiling.
P.L. 112-25 - The Budget Control Act of 2011 as it relates to coverage of dual eligibilities.
Educated about proposals to reform the Medicaid program and general issues related to deficit reduction.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Issues surrounding consolidation within the health care industry.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2011
In Q2, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on July 17, 2011.
Original Filing: 300391902.xml
Lobbying Issues
Educated staff about reforms to the TRICARE health program and its potential impact on military beneficiaries.
H.R. 1614 - Family Cord Blood Banking Act of 2011.
Agencies Lobbied
U.S. House of Representatives,
Lobbying Issues
Monitored deficit reduction initiatives related to enactment of an increase in the U.S. federal debt ceiling.
Educated about proposals to reform the Medicaid program and general issues related to deficit reduction.
Agencies Lobbied
U.S. House of Representatives,
1st Quarter, 2011
In Q1, W Strategies, LLC lobbied for UnitedHealth Group, Inc. , earning $50,000. The report was filed on April 16, 2011.
Original Filing: 300370109.xml
Lobbying Issues
Educated staff about reforms to the TRICARE health program and its potential impact on military beneficiaries.
Agencies Lobbied
U.S. House of Representatives,
Lobbying Issues
Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions addressing insurance reform and the Medicare Advantage Program.
Educated about proposals to reform the Medicaid program and general issues related to deficit reduction.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2011
W Strategies, LLC filed a lobbying registration on Feb. 8, 2011 to represent UnitedHealth Group, Inc., effective Jan. 1, 2011.
Original Filing: 300357744.xml
Issue(s) they said they’d lobby about: Monitoring the implementation of the Patient Protection and Affordable Care Act, including provisions addressing insurance reform and the Medicare Advantage program. .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate